Hemolytic-uremic syndrome during therapy with estramustine phosphate for advanced prostatic cancer.

Author: IorioD, PanziniI, RavaioliA, SartoriS, TassinariD

Paper Details 
Original Abstract of the Article :
3 weeks after commencing treatment with estramustine phosphate, typical manifestations of hemolytic-uremic syndrome occurred in a 66-year-old patient with prostate cancer. Urinary tract obstructions were excluded and no renal damage could be identified. An improvement in renal function was achieved ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1159/000011950

データ提供:米国国立医学図書館(NLM)

Estramustine Phosphate: A Side Effect in the Desert of Cancer Treatment

This research describes a patient who developed hemolytic-uremic syndrome (HUS) – a serious condition affecting the kidneys – after starting treatment with estramustine phosphate for prostate cancer. This case report highlights the potential for unexpected side effects from medications, even those used to treat serious conditions like cancer. It emphasizes the importance of vigilant monitoring and careful consideration of potential risks and benefits of medications.

Unexpected Side Effects: A Reminder of Complexity

This case report is a reminder that even seemingly safe medications can have unexpected side effects. It's like discovering a hidden canyon in the desert – a seemingly safe path can lead to an unexpected and potentially dangerous situation. This study underscores the importance of closely monitoring patients for any signs of adverse effects from medications.

Living Well With Cancer Treatment

This research emphasizes the importance of open communication with your doctor about any concerns you may have regarding your treatment. It's a reminder that cancer treatment can be complex, and that understanding potential risks and benefits is essential for making informed decisions about your care.

Dr.Camel's Conclusion

This case report serves as a cautionary tale, reminding us that even in the desert of cancer treatment, where every step is crucial, there can be unexpected dangers lurking beneath the surface. It's a reminder that vigilance and open communication are essential for navigating the complexities of healthcare.

Date :
  1. Date Completed 1999-03-18
  2. Date Revised 2017-11-01
Further Info :

Pubmed ID

9949296

DOI: Digital Object Identifier

10.1159/000011950

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.